Haemaday Tablet is a specialized formulation combining L-Methyl Folate (300 mg), Methylcobalamin (500 mcg), and Iron (100 mg) designed to support hematopoiesis and address nutritional deficiencies associated with anemia. L-Methyl Folate, the bioactive form of folic acid, plays a crucial role in DNA synthesis and red blood cell formation, enhancing folate bioavailability especially in individuals with folate metabolism impairments. Methylcobalamin, an active form of vitamin B12, is essential for neurological function and red blood cell maturation, preventing megaloblastic anemia. The inclusion of elemental Iron at 100 mg aids in replenishing iron stores, facilitating hemoglobin synthesis and oxygen transport. Haemaday Tablet is indicated for the treatment and prevention of iron deficiency anemia, megaloblastic anemia due to folate or B12 deficiency, and during increased physiological demands such as pregnancy, lactation, or chronic blood loss. The combination ensures synergistic action, improving hematologic parameters and reducing symptoms like fatigue, pallor, and weakness. It is recommended to be taken under medical supervision, with dosage adjusted based on individual patient requirements and laboratory findings. Caution is advised in patients with iron overload disorders or hypersensitivity to any component. Regular monitoring of hematological indices is essential to assess therapeutic efficacy and prevent adverse effects.